ArticleMolecular biology reports2025
Whole-exome sequencing reveals a novel variant in two Iranian families with autosomal recessive primary microcephaly.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicrocephaly primary hereditary (MCPH) is characterized by a reduced occipitofrontal circumference. We assessed the clinical and genetic characteristics of three Iranian individuals from two consanguineous families diagnosed with MCPH. METHODS AND
resultsProbands underwent whole-exome sequencing (WES). Sanger sequencing was used to confirm the candidate mutation and to analyze segregation within family members. Various in silico tools were employed to evaluate the impact of the identified variant on the structure and function of the associated protein. Additionally, RT-PCR was conducted to examine how the identified variant affected the size of the mRNA. A novel homozygous variant, NM_001083961.1: c.2115 C > T: p.(Gly705=), located in exon 17 of WDR62 gene, known to be a causative factor for MCPH2, was discovered in all three individuals with primary microcephaly. Notably, some phenotypic variability and new clinical features were observed among our patients. Although this variant is synonymous, it creates a new donor splicing site in exon 17 that connects with the acceptor splicing site of the adjacent intron 17, leading to the deletion of 33 nucleotides from exon 17. Although this deletion does not alter the reading frame, it removes 11 essential amino acids necessary for the normal functioning of WDR62. Gel electrophoresis and sequencing of RT-PCR products confirmed the presence of this 33-nucleotide deletion.
conclusionsOur findings broaden the range of identified mutations in the WDR62 gene and expand the clinical spectrum of MCPH2, highlighting the effectiveness and cost-efficiency of WES for molecular diagnosis in genetically diverse disorders such as MCPH.
Indexed as
Identifiers
40694266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.